Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

US Patent 11524022 · Granted Dec 13, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucl2025
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucl2025
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucl2025
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucl2025
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucl2025
Methods and compositions for treating motor neuron diseases2025
Quinoxalinone compounds, compositions, methods, and kits for increasing genome e2025
Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors2025
Nicotinamide riboside for use in treating or preventing liver damage2024
Nicotinamide riboside for use in treating or preventing liver damage2024
Crystalline forms of nicotinamide riboside chloride2024
Crystalline forms of nicotinamide riboside chloride2024